Joel Thomson - Student Research and Creativity Forum - Hofstra University

Page 1

electrophoresed on denaturing and reducing 10% polyacrylamide gels and transferred to nitrocellulose membrane. Membranes were blocked in 5% nonfat dry milk andthenincubatedwiththeappropriateprimary(1:1000)and secondaryantibody(1:5000).Secondaryantibodybindingwas visualizedusingchemiluminescencedetectiontechnology.

Cell Invasion Assay Matrigel was diluted in 0.01 Tris-HCL/0.7% NaCl, filter sterilized and 0.1 mLwas used to coatindividualBDBioCoatinserts(Millicell-PCF,0.4mm,12 mm, PIHP01250). Cells (2.5 x 104) were plated in 100 ml growth medium supplemented with 1% FBS into the upper chambersoftheinserts.Thelowerchamberscontainedgrowth medium supplemented with 10% FBS. After invasion, membranes were harvested and the surface of upper membraneswererinsedwithPBStoremoveunattachedcells.

Membraneswerefixedin4%paraformaldehyde,stainedwith 1 mg/mL DAPI, and the underside of the membrane was photographed using an inverted fluorescent microscope and cellswerequantitated.

SpheroidFormationAssay:CAL33cellsweredissociatedwith trypsin, then centrifuged at 1000 RPM for 5 minutes. Cells were resuspended in a DMEM solution supplemented with FCS to inactivate the trypsin, then centrifuged again and washed in spheroid media to remove the FCS. These washed cells were then plated for spheroid growth in ultra-low attachment dishes containing spheroid medium consisting of (DMEM/F12 (1:1) with 2% B27 supplement, 20 ng/ml EGF, 0.4% bovine serum albumin and 4 μg/ml insulin. Spheroids numberwasmonitoredover9daysofgrowth.

TINAGL1 is an EGFR antagonist that suppresses the aggressive phenotype

After 24 h the membrane was

rinsed and

Nuclei were

and

on

cells stably expressing constitutively active STAT3 were seeded for invasion assays, and then treated with Cetuximab or membrane was removed, rinsed and fixed. Nuclei were DAPI stained and counted on the underside of the membrane. *, ** P < 0.05 (the double asterisk indicates significance These findings indicate that R-TINAGL1 suppression of HNSCC invasion is dependent on suppression of STAT3 activity.

Conclusions

TINAGL1interactswithEGFR, β1and β4integrinand suppressestheiractivation

Treatment with R-TINAGL1 impairs spheroid formation,invasionandmigration

R-TINAGL1 suppression of the aggressive phenotype mimics phenotypic changes seen with Cetuximab treatment

R-TINAGL1suppressionoftheaggressivephenotypeis mediated by suppression of STAT3 signaling, with STAT3C rescuing the aggressive phenotype in the presenceofR-TINAGL1

R-TINAGL1 treatment represents a potential therapeutic strategy in HNSCC to impair EGFR/STAT3signalingandsuppresstheaggressive phenotype

STATTIC.
removed,
fixed.
DAPI stained
counted
the underside Cal33
F
C A C D

Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.